Qi Zhao
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Glycosylation and Glycoproteins Research 11
- Immunology 66
- Immunotherapy and Immune Responses 26
- Immune cells in cancer 13
- Co-authors
- Shigao Huang (9 shared papers)Jie Yang (6 shared papers)Otávia L. Caballero (10 shared papers)Zhuang Liu (5 shared papers)Liang Cheng (5 shared papers)Simon Fong (5 shared papers)Guangyu Zhou (5 shared papers)Christine Feig (2 shared papers)
- Journals
- International Journal of Biological Sciences (10 papers)PLoS ONE (8 papers)Scientific Reports (7 papers)Small (6 papers)Journal of Virology (5 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Qi Zhao
357 papers receiving 12.9k citations
Qi Zhao's Hit Papers
Peers
Comparison fields: 5 of 188
- Oncology 2.9k
- Immunology 2.3k
- Health Informatics 126
- Cancer Research 1.1k
- Infectious Diseases 1.2k
Countries citing papers authored by Qi Zhao
This map shows the geographic impact of Qi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Zhao more than expected).
Fields of papers citing papers by Qi Zhao
This network shows the impact of papers produced by Qi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Zhao. The network helps show where Qi Zhao may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 380 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer Hit paper breakdown → | 2013 | 1562 |
| 2 | Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases Hit paper breakdown → | 2005 | 576 |
| 3 | Perfluorocarbon‐Loaded Hollow Bi2Se3 Nanoparticles for Timely Supply of Oxygen under Near‐Infrared Light to Enhance the Radiotherapy of Cancer Hit paper breakdown → | 2016 | 551 |
| 4 | 2019 | 468 | |
| 5 | 2007 | 341 | |
| 6 | Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics Hit paper breakdown → | 2020 | 331 |
| 7 | 1997 | 321 | |
| 8 | 2013 | 314 | |
| 9 | Phototheranostic Metal-Phenolic Networks with Antiexosomal PD-L1 Enhanced Ferroptosis for Synergistic Immunotherapy Hit paper breakdown → | 2022 | 261 |
| 10 | 2019 | 251 | |
| 11 | 2020 | 197 | |
| 12 | 2006 | 194 | |
| 13 | 2020 | 175 | |
| 14 | Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective Hit paper breakdown → | 2023 | 169 |
| 15 | 2017 | 163 | |
| 16 | 1995 | 149 | |
| 17 | 2018 | 148 | |
| 18 | 2020 | 140 | |
| 19 | 2013 | 139 | |
| 20 | Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice Hit paper breakdown → | 2023 | 134 |
About Qi Zhao
Qi Zhao is a scholar working on Molecular Biology, Immunology, Biomedical Engineering, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 380 papers that have together received 13.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (49 papers), Monoclonal and Polyclonal Antibodies Research (29 papers), Immunotherapy and Immune Responses (26 papers), CAR-T cell therapy research (21 papers), Immune cells in cancer (13 papers), Natural Compounds in Disease Treatment (12 papers), Glycosylation and Glycoproteins Research (11 papers) and Drug Transport and Resistance Mechanisms (11 papers). The work is most often cited by research in Oncology (2.9k citations), Immunology (2.3k citations), Health Informatics (126 citations), Cancer Research (1.1k citations) and Infectious Diseases (1.2k citations). Qi Zhao has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Shigao Huang, Jie Yang, Otávia L. Caballero, Zhuang Liu, Liang Cheng, Simon Fong, Guangyu Zhou, Christine Feig, Andrew Deonarine and Douglas T. Fearon. Their work appears in journals such as International Journal of Biological Sciences, PLoS ONE, Scientific Reports, Small and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.